U.S. Healthcare Services Stock News

Thinking about LendingClub and what it means for your portfolio? You are not alone. With so much conversation swirling around growth stocks and the evolving fintech space, investors are wondering if now is the time to buy, sell, or simply watch from the sidelines. LendingClub’s recent share price tells an interesting story: dropping 10.8% in the past week and losing 11.1% over the past month, which might have some people nervous. But if you zoom out, the picture changes. The stock is still up...

Last month, GitLab reported strong second-quarter results and announced the appointment of Simon Mundy as Chief Accounting Officer, following the resignation of Brian Robins on September 19, 2025. Despite demand growth and ongoing AI initiatives, investor concerns surfaced due to weaker third-quarter revenue guidance and leadership transitions. We’ll explore how investor concerns about GitLab’s revenue projections and executive changes might influence its long-term investment...

Tencent Music Entertainment Group (NYSE:TME) shares have edged slightly lower over the past week, down 3%, continuing a downward drift for the month. Investors are paying attention to shifting sentiment following a lengthy run-up over the past 3 months. See our latest analysis for Tencent Music Entertainment Group. After a solid run over the last three months, Tencent Music’s recent dip has caught some eyes, but it still boasts a modest 1-year total shareholder return of 0.7%. However,...

On September 23, 2025, International Seaways, Inc. issued US$250 million of 7.125% senior unsecured bonds due 2030 at par, with interest to be paid semi-annually and application submitted for listing on the Oslo Stock Exchange. This financing incorporates financial covenants and distribution restrictions, which could shape the company's future balance sheet flexibility and access to capital. We'll now explore how this significant debt issuance and its covenants may influence International...

Progress Software delivered a series of announcements that grabbed investor attention this week. The company reported quarterly earnings that beat expectations, raised its full-year financial outlook, and launched a major new Center of Excellence in Costa Rica. See our latest analysis for Progress Software. Progress Software’s raised outlook, new AI product launches, and expanded buyback program have all boosted investor confidence recently. However, the one-year total shareholder return is...

Royal Caribbean Cruises (RCL) has just wrapped up a $1.5 billion offering of senior unsecured notes due 2036, setting the stage to fund the upcoming Celebrity Xcel ship and address existing debt. For investors, this move emphasizes the company’s improved access to capital and its intent to further strengthen its balance sheet. See our latest analysis for Royal Caribbean Cruises. Royal Caribbean Cruises has been making headlines, not just for its new $1.5 billion in debt financing, but also as...

Earlier this week, Citigroup downgraded Olin Corporation’s rating from Buy to Neutral, citing weaker market demand for chlorine derivatives and ongoing challenges in the epoxy sector. This shift in analyst sentiment highlights heightened concerns about Olin's ability to meet its future projections due to sector-specific and company-level financial risks. We'll examine how analyst caution about uncertain chemical sector demand and financial pressures could shift Olin's investment...

Fidelity National Financial (FNF) has caught investors’ attention as it continues to show steady growth, with a slight uptick in its latest closing price. Over the past month, the stock has remained fairly stable, prompting closer evaluation. See our latest analysis for Fidelity National Financial. Zooming out from the recent price action, Fidelity National Financial’s latest share price of $59.97 comes after a year marked by moderate momentum. While the 1-year total shareholder return stands...

Guardant Health (GH) just received expanded FDA approval for its Guardant360 CDx blood test. The test is now cleared to identify advanced breast cancer patients with ESR1 mutations who might benefit from Eli Lilly’s Inluriyo treatment. See our latest analysis for Guardant Health. Momentum has picked up for Guardant Health following a series of positive developments, including its FDA approval expansion for Guardant360 CDx and a high-profile partnership with Quest Diagnostics. The company’s...

Thinking about what to do with Humana stock? You are not alone. Investors have been watching the company's roller coaster ride with keen interest, trying to figure out if the current price represents opportunity or risk. Over the past week, for example, Humana shares have bounced back impressively, climbing 11.3%, a move that stands out especially against a tougher month in which the stock dropped 7.9%. Year to date, returns are up 12.3%, and if you look back one year, the stock’s up nearly...

In recent days, Danaher's Leica Biosystems unit announced the launch of new AI-powered digital pathology solutions, alongside favorable changes in US pharmaceutical tariffs supporting domestic companies in the sector. This combination of technological innovation and shifts in the regulatory landscape is enhancing confidence in Danaher's position within Life Sciences and Diagnostics. We'll examine how Danaher's new AI-powered pathology platform may support its narrative of recurring revenue...

Dave (NasdaqGM:DAVE) shares got a lift after the company beat expectations for the second quarter, sparking renewed optimism among analysts. Several firms reiterated or boosted their outlook, even with broader market worries in the sector. See our latest analysis for Dave. After a volatile year that saw sector uncertainty weighing on the stock, Dave has started to attract fresh optimism thanks to its standout quarterly results and a renewed sense of momentum from positive analyst coverage...

NorthWestern Energy Group (NWE) has seen its shares move slightly over the past month, drawing attention from investors curious about what is driving activity. Recently, the company’s performance metrics have been in focus. See our latest analysis for NorthWestern Energy Group. After a modest stretch of movement, NorthWestern Energy Group’s share price has held fairly steady, trading at $57.73. Despite a quiet few weeks, the company’s 1-year total shareholder return of 0.09% suggests that...

Pagaya Technologies (NasdaqCM:PGY) just expanded its revolving credit facility to $132 million, more than doubling the previous amount and securing a much lower interest rate. This move highlights the company’s growing access to capital and stable funding. See our latest analysis for Pagaya Technologies. Pagaya’s recent credit facility expansion comes at a time when investor sentiment is steadily improving. After a choppy spell earlier in the year, the stock’s one-year total shareholder...

TG Therapeutics and its partner Neuraxpharm recently presented updated six-year results from the ULTIMATE I & II Phase 3 trials of BRIUMVI® (ublituximab-xiiy) for relapsing multiple sclerosis at the 2025 ECTRIMS annual meeting, highlighting favorable efficacy and safety data across different administration approaches. These findings, including well-tolerated single-dose infusions and robust real-world consistency, may further support the adoption and broader use of BRIUMVI in clinical...

AbCellera Biologics recently reported second-quarter 2025 revenues of US$17.1 million, surpassing analyst expectations, largely due to a milestone payment from a Trianni license, and began dosing participants in a Phase 1 trial of its antibody therapy ABCL575. The company also appointed Sarah Noonberg as its first Chief Medical Officer, marking a step forward in its evolution into a clinical-stage biotech innovator. The significant milestone payment and launch of a first-in-human clinical...

InterDigital raised its third quarter 2025 earnings guidance, now expecting revenue between US$155 million and US$159 million and diluted EPS between US$1.39 and US$1.56, up from previous forecasts. This revised outlook follows increased analyst earnings estimates and strong momentum ratings, highlighting rising confidence in the company’s financial performance. We’ll examine how InterDigital’s improved guidance and higher analyst estimates may influence its investment narrative and future...

Lotus Technology (NasdaqGS:LOT) drew investor attention after announcing plans to showcase its Theory 1 concept car and unveil a Senna-inspired Emira Limited at IAA Mobility 2025 in Munich. The company continues to focus on product innovation, even though delivery numbers are lower this year. See our latest analysis for Lotus Technology. Lotus Technology’s announcement of its upcoming IAA Mobility 2025 showcase, despite a sharp 49% drop in Q2 deliveries, has reignited interest and suggests...

Dyne Therapeutics (DYN) just received Orphan Drug designation in Japan for its experimental drug DYNE-251, following encouraging results from the DELIVER trial. The company also named veteran executive Brian Posner to its board. See our latest analysis for Dyne Therapeutics. After gaining Orphan Drug status in Japan and welcoming a seasoned leader to its board, Dyne Therapeutics has caught more eyes in the biotech space. While the latest share price sits at $13.06, the 90-day share price...

Target (TGT) shares have seen some turbulence over the past month, with the stock dropping 4%. Investors tracking the retailer’s performance may be wondering how recent developments fit into the bigger picture for long-term value and growth. See our latest analysis for Target. While Target’s latest share price has dipped to $89.03, the stock’s longer-term momentum has remained underwhelming, with a 1-year total shareholder return of -39.5% and weaker multi-year performance suggesting that...

Li Auto (NasdaqGS:LI) just rolled out its new five-seat electric SUV, the Li i6, at the end of September and quickly received over 20,000 orders in a matter of hours. In addition, the company reported delivering nearly 34,000 vehicles in September and over 93,000 for the third quarter, continuing to highlight its place in China's premium SUV landscape. See our latest analysis for Li Auto. The buzz around Li Auto’s new i6 SUV launch and pledge to cover buyer tax incentives has sparked fresh...

Curbline Properties (CURB) just rolled out a $250 million share repurchase program along with a $250 million at-the-market equity offering, aiming to boost its financial flexibility and deliver value for shareholders. See our latest analysis for Curbline Properties. Fresh off a well-received share repurchase program and equity offering, Curbline Properties is making waves in the retail REIT space by closing significant acquisitions and drawing positive attention from analysts. After a year...

Trying to make sense of Taiwan Semiconductor Manufacturing’s stock movements lately? You’re not alone. Whether you’re already holding shares, thinking about buying in, or just watching from the sidelines, recent gains have been hard to ignore. TSMC’s share price has climbed an impressive 20.0% over the past month and 44.9% year to date, with a stellar 63.1% rise in the last 12 months. If you zoom out even further, the stock has delivered more than 250% in five years. These explosive numbers...

If you’re weighing whether to hold, buy, or sell Kraft Heinz stock right now, you’re not alone. The past five years have been anything but boring for shareholders, with the stock delivering a modest 5.3% gain over that period, despite some seriously choppy trading along the way. Most recently, the shares have slipped by 15.3% year-to-date and are down 20.4% over the past year. Even the past month hasn’t given much reason for cheer, with a decline of 4.5%. So, what’s driving these moves?...